Citadel Advisors’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-128,707
| Closed | -$135K | – | 14070 |
|
|
2022
Q2 | $165K | Buy |
128,707
+117,182
| +1,017% | +$154K | ﹤0.01% | 10887 |
|
|
2022
Q1 | $16K | Sell |
11,525
-11,461
| -50% | -$24.5K | ﹤0.01% | 13309 |
|
|
2021
Q4 | $63K | Sell |
22,986
-30,206
| -57% | -$111K | ﹤0.01% | 13116 |
|
|
2021
Q3 | $253K | Buy |
+53,192
| New | +$388K | ﹤0.01% | 11457 |
|
|
2021
Q2 | – | Sell |
-21,374
| Closed | -$178K | – | 14737 |
|
|
2021
Q1 | $171K | Sell |
21,374
-54,115
| -72% | -$504K | ﹤0.01% | 11905 |
|
|
2020
Q4 | $675K | Buy |
75,489
+58,255
| +338% | +$484K | ﹤0.01% | 7568 |
|
|
2020
Q3 | $130K | Sell |
17,234
-228,255
| -93% | -$1.58M | ﹤0.01% | 9107 |
|
|
2020
Q2 | $1.56M | Buy |
245,489
+110,631
| +82% | +$740K | ﹤0.01% | 4999 |
|
|
2020
Q1 | $1M | Sell |
134,858
-87,032
| -39% | -$674K | ﹤0.01% | 5332 |
|
|
2019
Q4 | $2M | Buy |
221,890
+107,148
| +93% | +$901K | ﹤0.01% | 4420 |
|
|
2019
Q3 | $860K | Buy |
114,742
+62,101
| +118% | +$348K | ﹤0.01% | 5849 |
|
|
2019
Q2 | $273K | Sell |
52,641
-267,565
| -84% | -$1.74M | ﹤0.01% | 7728 |
|
|
2019
Q1 | $2.68M | Sell |
320,206
-307,600
| -49% | -$2.21M | ﹤0.01% | 3965 |
|
|
2018
Q4 | $2.7M | Buy |
627,806
+366,665
| +140% | +$3.24M | ﹤0.01% | 3694 |
|
|
2018
Q3 | $3.8M | Buy |
261,141
+34,924
| +15% | +$579K | ﹤0.01% | 3365 |
|
|
2018
Q2 | $4.21M | Buy |
226,217
+151,548
| +203% | +$2.74M | ﹤0.01% | 2992 |
|
|
2018
Q1 | $1.3M | Sell |
74,669
-25,067
| -25% | -$442K | ﹤0.01% | 4409 |
|
|
2017
Q4 | $1.68M | Buy |
99,736
+29,635
| +42% | +$482K | ﹤0.01% | 3883 |
|
|
2017
Q3 | $1.1M | Buy |
70,101
+14,339
| +26% | +$205K | ﹤0.01% | 4177 |
|
|
2017
Q2 | $736K | Buy |
55,762
+38,554
| +224% | +$507K | ﹤0.01% | 4560 |
|
|
2017
Q1 | $205K | Buy |
17,208
+4,009
| +30% | +$48.1K | ﹤0.01% | 6485 |
|
|
2016
Q4 | $172K | Sell |
13,199
-54,763
| -81% | -$630K | ﹤0.01% | 6411 |
|
|
2016
Q3 | $759K | Buy |
+67,962
| New | +$818K | ﹤0.01% | 4206 |
|
|
2016
Q2 | – | Sell |
-13,549
| Closed | -$178K | – | 7581 |
|
|
2016
Q1 | $178K | Buy |
+13,549
| New | +$192K | ﹤0.01% | 5720 |
|
|
2015
Q3 | – | Sell |
-78,726
| Closed | -$1.7M | – | 9345 |
|
|
2015
Q2 | $1.7M | Sell |
78,726
-58,410
| -43% | -$1.24M | ﹤0.01% | 3249 |
|
|
2015
Q1 | $2.66M | Buy |
137,136
+48,046
| +54% | +$832K | ﹤0.01% | 2715 |
|
|
2014
Q4 | $1.49M | Sell |
89,090
-22,234
| -20% | -$337K | ﹤0.01% | 3258 |
|
|
2014
Q3 | $1.31M | Buy |
+111,324
| New | +$1.7M | ﹤0.01% | 3365 |
|
|
2014
Q2 | – | Sell |
-76,287
| Closed | -$1.45M | – | 8416 |
|
|
2014
Q1 | $1.45M | Buy |
+76,287
| New | +$1.57M | ﹤0.01% | 2963 |
|
|
2013
Q4 | – | Sell |
-44,584
| Closed | -$770K | – | 7217 |
|
|
2013
Q3 | $770K | Sell |
44,584
-31,946
| -42% | -$507K | ﹤0.01% | 3367 |
|
|
2013
Q2 | $1.1M | Buy |
+76,530
| New | +$1.06M | ﹤0.01% | 3097 |
|
Other funds holding IVC
AGAM
HCM
Citadel Advisors's IVC Position: Q3 2022 in Review
Citadel Advisors sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 128,707 shares — an estimated $135K sold.
Citadel Advisors first reported a position in IVC in Q2 2013 and held it in 31 quarters. The position peaked at $4.21M in Q2 2018. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.
- Citadel Advisors reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 128,707 Invacare Corporation shares in Q3 2022, an estimated $135K.
- Citadel Advisors first reported a position in Invacare Corporation in Q2 2013 and held it in 31 quarters.
- Citadel Advisors's Invacare Corporation position peaked at $4.21M in Q2 2018.
- 72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.